inserisco a tal proposito le indicazioni che ha avuto hellouser sul seti al congresso: (peccato non abbia chiesto per il veicolante)
hrough another source I can confirm this:
Follica is fully alive and still undergoing clinical trials. They we're in 'hibernation mode' but that's all that can be said.
Now, in regards to the PGD2 stuff, this is where I was able to get some answers. So I'll go down the list:
1) Solutions like Setipiprant and AM211 (I have a presentation on that as well which I'll post soon) or other PGD2 inhibitors, SHOULD work just as well topically as they would orally if they go systemic. However, I also asked if they didn't go systemic, would they still be effective in blocking PGD2 in the follicles environment and he answered yes.
2) The inhibitors are not dose dependant.
3) PGD2 levels in early vs. late study baldness have NOT been examined as they don't get tissue for late stage baldness.
4) AM211 works similarly to Setipiprant, but are not dose dependant but had some purity issues.
5) He says he'd be shocked if the congress passed the 21st century act.
6) Dosing for setipiprant would depend on the levels in the skin.
That's all guys!
Many thanks to Dr. Cotsarelis as well for speaking with me! This guy's tough to get a hold of, just wish we could know more about Follica and the wounding protocol.a
hrough another source I can confirm this:
Follica is fully alive and still undergoing clinical trials. They we're in 'hibernation mode' but that's all that can be said.
Now, in regards to the PGD2 stuff, this is where I was able to get some answers. So I'll go down the list:
1) Solutions like Setipiprant and AM211 (I have a presentation on that as well which I'll post soon) or other PGD2 inhibitors, SHOULD work just as well topically as they would orally if they go systemic. However, I also asked if they didn't go systemic, would they still be effective in blocking PGD2 in the follicles environment and he answered yes.
2) The inhibitors are not dose dependant.
3) PGD2 levels in early vs. late study baldness have NOT been examined as they don't get tissue for late stage baldness.
4) AM211 works similarly to Setipiprant, but are not dose dependant but had some purity issues.
5) He says he'd be shocked if the congress passed the 21st century act.
6) Dosing for setipiprant would depend on the levels in the skin.
That's all guys!
Many thanks to Dr. Cotsarelis as well for speaking with me! This guy's tough to get a hold of, just wish we could know more about Follica and the wounding protocol.a
